November 26, 2024- Amsino International Inc. announced the successful closing of transactions to acquire the assets of MedXL Inc. and Liebel-Flarsheim Canada Inc. (collectively, “MedXL”, or the “Company”) located in Montreal, Quebec, Canada. This acquisition includes substantially all of the existing assets and infrastructure at MedXL facilities, such as intellectual property, real estate, manufacturing equipment, and global product registrations in approximately 60 countries.
All MedXL’s facilities are FDA and Health Canada registered and certified globally in all key markets for regulatory compliance. The MedXL acquisition includes a wide range of exciting new products including Praxiject™ 0.9% sodium chloride injection USP prefilled syringes, CitraFlow™ sodium citrate prefilled syringes, and CitraFlow PLUS™ citrate-ethanol prefilled syringes with anticoagulant and antimicrobial properties designed to help reduce incidents of catheter-related bloodstream infections. For more detailed product information visit www.amsino.com/medXL.